| Literature DB >> 35327354 |
Annekathrin Ücker1,2, Stephan Baumgartner1,3,4, David Martin1, Tim Jäger1,2,3.
Abstract
European Pharmacopoeia monograph 2371 describes the production of homeopathic preparations. A specific efficacy of these preparations in high dilution levels is questionable in view of basic scientific principles. There is empirical evidence for such effects, for example in a Lemna-intoxication bioassay published 2010. To test the replicability and robustness of this bioassay, we conducted two experimental series (five independent blinded and randomised experiments each). The specimen of Lemna gibba L., clone-number 9352, were stressed in arsenic solution for 48 h (158 mg/L AsNa2HO4 (250 mg/L in series 2)), then grew in either As2O3 preparations produced according to Eu. Pharm. Monogr. 2371 or control solution. Comparing the area-related relative growth rate of day 3-9 (rgr 3-9) between treatment and control groups for each series showed differences that were not significant in series 1 (p = 0.10), significant in series 2 (p = 0.04) and significant in the pooled data of both series (p < 0.01). The effect direction (rgr 3-9 increase) was comparable to experiments of 2010, but the effect size was smaller, likely due to a changed light cycle. These results are not compatible with the hypothesis that the application of European Pharmacopoeia monograph 2371 results in pharmaceutical preparations without specific effects. Further studies are needed to investigate a potential mode of action explaining these effects.Entities:
Keywords: Lemna gibba; duckweed bioassay; in vitro bioassay; praeparationes homoeopathicae; systematic negative control experiment
Year: 2022 PMID: 35327354 PMCID: PMC8944999 DOI: 10.3390/biomedicines10030552
Source DB: PubMed Journal: Biomedicines ISSN: 2227-9059
Overview of experimental series concerning location, time and general setting of single experiments; * 10 data points were removed from SNC for alignment according to verum experiments. Sample size refers to the number of beakers with Lemna gibba L. No. non-stressed = number of beakers with Lemna gibba L. that were not pre-treated with 158 or 250 mg/mL AsNa2HO4. Chamber 0: see (Jäger et al. 2010 [13]); chamber 1 and 2: see Figure 1; differences between ImageJ analysis software “imageJ A” and “imageJ B” see Section 4.3.2 and Supplement A.
| Series | Arsenic Concentration [mg/L] | Experiment | Corresponding Verum Experiment | Light Cycle | Location | Chamber | Start of Experiment | Early Time Period [d] | Late Time Period [d] | Sample Size Control/Treatment | No. | Image Analysis Software | Starting | Used Potency Levels |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 158 | Verum 6 | 16:08 | Freiburg | Chamber 1 | 11 March 2017 | 0–3 | 3–9 | 40/40 | 4 | imageJ A | 5x dilution | 17x, 18x, 20–23x, 28x, 30x, 33x | |
| Verum 7 | 16:08 | Freiburg | Chamber 1 | 1 April 2017 | 0–3 | 3–9 | 40/40 | 4 | imageJ A | 5x dilution | 17x, 18x, 20–23x, 28x, 30x, 33x | |||
| Verum 8 | 16:08 | Arlesheim | Chamber 1 | 13 February 2018 | 0–3 | 3–9 | 30/40 | 3 | imageJ A | 5x dilution | 17x, 18x, 20–23x, 28x, 30x, 33x | |||
| Verum 9 | 16:08 | Arlesheim | Chamber 1 | 9 March 2018 | 0–3 | 3–9 | 30/40 | 4 | imageJ A | 5x dilution | 17x, 18x, 20–23x, 28x, 30x, 33x | |||
| Verum 10 | 16:08 | Arlesheim | Chamber 2 | 11 May 2018 | 0–3 | 3–9 | 30/40 | 4 | imageJ A | 5x dilution | 17x, 18x, 20–23x, 28x, 30x, 33x | |||
| SNC 6 | Verum 6 | 16:08 | Freiburg | Chamber 1 | 2 July 2016 | 0–3 | 3–9 | 40/40 | 2 | imageJ A | 5x dilution | 17x, 18x, 20–23x, 28x, 30x, 33x | ||
| SNC 7 | Verum 7 | 16:08 | Freiburg | Chamber 1 | 15 April 2017 | 0–3 | 3–9 | 40/40 | 4 | imageJ A | 5x dilution | 17x, 18x, 20–23x, 28x, 30x, 33x | ||
| SNC 8 * | Verum 8 | 16:08 | Arlesheim | Chamber 1 | 20 October 2017 | 0–3 | 3–9 | 30/40 | 5 | imageJ A | 5x dilution | 17x, 18x, 20–23x, 28x, 30x, 33x | ||
| SNC 9 * | Verum 9 | 16:08 | Arlesheim | Chamber 1 | 1 December 2017 | 0–3 | 3–9 | 30/40 | 4 | imageJ A | 5x dilution | 17x, 18x, 20–23x, 28x, 30x, 33x | ||
| SNC 10 | Verum 10 | 16:08 | Arlesheim | Chamber 1 | 12 January 2019 | 0–3 | 3–9 | 30/40 | 4 | imageJ A | 5x dilution | 17x, 18x, 20–23x, 28x, 30x, 33x | ||
| 2 | 250 | Verum 11 | 16:08 | Arlesheim | Chamber 1 | 20 July 2018 | 0–3 | 3–9 | 30/40 | 5 | imageJ B | 5x dilution | 17x, 18x, 20–23x, 28x, 30x, 33x | |
| Verum 12 | 16:08 | Arlesheim | Chamber 1 | 7 September 2018 | 0–3 | 3–9 | 30/40 | 5 | imageJ B | 5x dilution | 17x, 18x, 20–23x, 28x, 30x, 33x | |||
| Verum 13 | 16:08 | Arlesheim | Chamber 1 | 7 December 2018 | 0–3 | 3–9 | 30/40 | 5 | imageJ B | 5x dilution | 17x, 18x, 20–23x, 28x, 30x, 33x | |||
| Verum 14 | 16:08 | Arlesheim | Chamber 2 | 23 May 2019 | 0–3 | 3–9 | 40/40 | 5 | imageJ B | 5x dilution | 17x, 18x, 20–23x, 28x, 30x, 33x | |||
| Verum 15 | 16:08 | Arlesheim | Chamber 2 | 1 August 2019 | 0–3 | 3–9 | 40/40 | 5 | imageJ B | 5x dilution | 17x, 18x, 20–23x, 28x, 30x, 33x | |||
| SNC 11 * | Verum 11 | 16:08 | Arlesheim | Chamber 2 | 9 May 2019 | 0–3 | 3–9 | 30/40 | 4 | imageJ B | 5x dilution | 17x, 18x, 20–23x, 28x, 30x, 33x | ||
| SNC 12 * | Verum 12 | 16:08 | Arlesheim | Chamber 2 | 18 July 2019 | 0–3 | 3–9 | 30/40 | 4 | imageJ B | 5x dilution | 17x, 18x, 20–23x, 28x, 30x, 33x | ||
| SNC 13 * | Verum 13 | 16:08 | Arlesheim | Chamber 2 | 7 November 2019 | 0–3 | 3–9 | 30/40 | 4 | imageJ B | 5x dilution | 17x, 18x, 20–23x, 28x, 30x, 33x | ||
| SNC 14 | Verum 14 | 16:08 | Arlesheim | Chamber 2 | 21 Nevember 2019 | 0–3 | 3–9 | 40/40 | 5 | imageJ B | 5x dilution | 17x, 18x, 20–23x, 28x, 30x, 33x | ||
| SNC 15 | Verum 15 | 16:08 | Arlesheim | Chamber 2 | 5 December 2019 | 0–3 | 3–9 | 40/40 | 5 | imageJ B | 5x dilution | 17x, 18x, 20–23x, 28x, 30x, 33x | ||
| 0 | 158 | Verum 1 | 24:00 | Frick | Chamber 0 | 25 March 2009 | 0–2 | 2–6 | 45/45 | 5 | Scanalyzer | 5x trituration | 17x, 18x, 20–24x, 28x, 30x, 33x | |
| (orig. | Verum 2 | 24:00 | Frick | Chamber 0 | 3 June 2009 | 0–2 | 2–6 | 45/45 | 5 | Scanalyzer | 5x trituration | 17x, 18x, 20–24x, 28x, 30x, 33x | ||
| series) | Verum 3 | 24:00 | Frick | Chamber 0 | 29 July 2009 | 0–2 | 2–6 | 45/45 | 5 | Scanalyzer | 5x trituration | 17x, 18x, 20–24x, 28x, 30x, 33x | ||
| Verum 4 | 24:00 | Frick | Chamber 0 | 12 August 2009 | 0–2 | 2–6 | 45/45 | 5 | Scanalyzer | 5x trituration | 17x, 18x, 20–24x, 28x, 30x, 33x | |||
| Verum 5 | 24:00 | Frick | Chamber 0 | 28 August 2009 | 0–2 | 2–6 | 45/45 | 5 | Scanalyzer | 5x trituration | 17x, 18x, 20–24x, 28x, 30x, 33x | |||
| SNC 1 | Verum 1 | 24:00 | Frick | Chamber 0 | 20 January 2009 | 0–2 | 2–6 | 45/45 | 5 | Scanalyzer | 5x trituration | 17x, 18x, 20–24x, 28x, 30x, 33x | ||
| SNC 2 | Verum 2 | 24:00 | Frick | Chamber 0 | 22 April 2009 | 0–2 | 2–6 | 45/45 | 5 | Scanalyzer | 5x trituration | 17x, 18x, 20–24x, 28x, 30x, 33x | ||
| SNC 3 | Verum 3 | 24:00 | Frick | Chamber 0 | 10 June 2009 | 0–2 | 2–6 | 45/45 | 5 | Scanalyzer | 5x trituration | 17x, 18x, 20–24x, 28x, 30x, 33x | ||
| SNC 4 | Verum 4 | 24:00 | Frick | Chamber 0 | 8 July 2009 | 0–2 | 2–6 | 45/45 | 5 | Scanalyzer | 5x trituration | 17x, 18x, 20–24x, 28x, 30x, 33x | ||
| SNC 5 | Verum 5 | 24:00 | Frick | Chamber 0 | 2 September 2009 | 0–2 | 2–6 | 45/45 | 5 | Scanalyzer | 5x trituration | 17x, 18x, 20–24x, 28x, 30x, 33x |
Figure 1Growth chambers. (A) Chamber 1; (B) experimental field of chamber 1; (C) Chamber 2; (D) experimental field of chamber 2; due to different geometry of chamber 1 and chamber 2, the experimental field had to be modified to yield comparable conditions in temperature and air movement.
Figure 2Sorting of duckweed prior to an experiment. Three groups of 85 fronds each were sorted. Duckweed fronds within each group had to be as similar as possible concerning symmetry and surface area. Additionally, fronds had to be non-chlorotic (whitening of the plant caused by the degradation of chlorophyll) and showing new small roots and daughter fronds. Figure 2 shows sorted plants stressed with 250 mg/L AsNa2HO4 for 48 h.
Coefficient of variance (CV) for relative growth rates in the systematic negative control experiments of both experimental series, representing variance between randomisation groups of each experiment (CV = SD × 100/mean, based on mean values of randomisation groups).
| CV Series 1 | Early Time | Late Time | CV Series 2 | Early Time | Late Time |
|---|---|---|---|---|---|
| SNC 1 | 3.00 | 2.27 | SNC 1 | 1.20 | 1.38 |
| SNC 2 | 1.35 | 1.25 | SNC 2 | 1.66 | 1.24 |
| SNC 3 | 2.02 | 0.83 | SNC 3 | 1.69 | 0.97 |
| SNC 4 | 1.96 | 0.79 | SNC 4 | 1.65 | 0.86 |
| SNC 5 | 0.90 | 0.73 | SNC 5 | 2.59 | 1.04 |
| SNC 1–5 | 1.78 | 1.14 | SNC 1–5 | 1.75 | 1.10 |
Figure 3Morphological changes induced by different concentrations of AsNa2HO4 on Lemna gibba L. by 48 h incubation resulted in the separation of mother and daughter fronds (leaf-like structure). (A) 158 mg/L AsNa2HO4 plants prior to sorting (B) 250 mg/L AsNa2HO4 plants prior to sorting (C) 158 mg/L AsNa2HO4 sorted and (D) 250 mg/L AsNa2HO4 sorted. (C,D) have the same scale. Blue circles indicate plants considered optimal for experiments. Diameter of fronds and daughter fronds are smaller after stress with 250 mg/L AsNa2HO4 (see A) compared to 158 mg/L AsNa2HO4 (see B). Blue rectangles indicate severely stressed plants, recognisable by their droplet-like morphology. Their number increases with a higher arsenic stress. More severely stressed plants have a tendency to develop chlorosis (whitening due to loss of chlorophyll).
Figure 4Mean relative growth rates (±95% CI) of duckweed of five SNC experiments in each series (1/2) for numerically pooled data of pseudo-treatment (n = 200) and pseudo-control group (n = 170) for (A) series 1 (early time period, day 0–3); (B) series 1 (late time period, day 3–9); (C) series 2 (early time period, day 0–3); and (D) series 2 (late time period, day 3–9).
Figure 5Mean relative growth rate (±95% CI) of duckweed treated with either potentised As2O3 (potency levels 17x–18x, 21x–23x, 28x, 30x, 33x, numerically pooled, n = 200) or water as control (unsuccussed and succussed water samples, numerically pooled, n = 170) in the 5 independent experiments of series 1. (A) Early time period (day 0–3), (B) Late time period (day 3–9).
Figure 6Mean relative growth rate (±95% CI) of duckweed treated with either potentised As2O3 (potency levels 17x–18x, 21x–23x, 28x, 30x, 33x, numerically pooled, n = 25 each) or water as control (unsuccussed and succussed water samples, numerically pooled, n = 85 each) in the 5 independent experiments of series 1. (A) Early time period (day 0–3), (B) Late time period (day 3–9). The red line represents the mean of water controls.
Statistical analysis of experimental series 1. Results of two-way ANOVA of series 1 for numerically pooled treatment (As2O3 17x–18x, 21x–23x, 28x, 30x, and 33x) and numerically pooled control (unsuccussed and succussed water) groups for n = 5 independent experiments in the early (day 0–3) and late time period (day 3–9). df—degree of freedom. Significant values are printed bold.
| Series 1 | df | Sum of Squares | F Ratio | |
|---|---|---|---|---|
| Treatment group | 1 | 0.00000023 | 0.0013 | 0.9712 |
| Experiment number | 4 | 0.08786236 | 125.4573 |
|
| Interaction | 4 | 0.00027976 | 0.3995 | 0.809 |
|
|
|
|
|
|
| Treatment group | 1 | 0.00019524 | 2.7635 | 0.0973 |
| Experiment number | 4 | 0.06368114 | 225.3325 |
|
| Interaction | 4 | 0.0004133 | 1.4624 | 0.2131 |
Statistical analysis of experimental series 1. Results of a two-way ANOVA of series 1 for single treatment (As2O3 17x–18x, 21x–23x, 28x, 30x, and 33x) and control (unsuccussed and succussed water) groups for n = 5 experiments in early (day 0–3) and late time period (day 3–9). df—degree of freedom. Significant values are printed bold.
| Series 1 | df | Sum of Squares | F Ratio | |
|---|---|---|---|---|
| Treatment group | 9 | 0.00057831 | 0.3431 | 0.9599 |
| Experiment number | 4 | 0.0612927 | 81.8193 |
|
| Interaction | 36 | 0.00275917 | 0.4092 | 0.9991 |
|
|
|
|
|
|
| Treatment group | 9 | 0.00029427 | 0.4437 | 0.9106 |
| Experiment number | 4 | 0.04412396 | 149.7021 |
|
| Interaction | 36 | 0.00217615 | 0.8204 | 0.7605 |
Statistical analysis of experimental series 2. Results of two-way ANOVA of series 2 for numerically pooled treatment groups (As2O3 17x–18x, 21x–23x, 28x, 30x, and 33x) and numerically pooled control groups (unsuccussed and succussed water) for n = 5 independent experiments in the early (day 0–3) and late time period (day 3–9). df—degree of freedom. Significant values are printed bold.
| Series 2 | df | Sum of Squares | F Ratio | |
|---|---|---|---|---|
| Treatment group | 1 | 0.00000771 | 0.0705 | 0.7908 |
| Experiment number | 4 | 0.21284402 | 486.3185 |
|
| Interaction | 4 | 0.0005176 | 1.1826 | 0.3181 |
|
|
|
|
|
|
| Treatment group | 1 | 0.00029398 | 4.0814 |
|
| Experiment number | 4 | 0.03503934 | 121.617 |
|
| Interaction | 4 | 0.0002879 | 0.9993 | 0.4079 |
Figure 7Mean relative growth rate (±95% CI) of duckweed treated with either potentised As2O3 (potency levels 17x–18x, 21x–23x, 28x, 30x, 33x, numerically pooled, n = 200) or water as control (unsuccussed and succussed water samples, numerically pooled, n = 170) in the 5 independent experiments of series 2. (A) Early time period (day 0–3), (B) Late time period (day 3–9), * p < 0.05.
Statistical analysis of experimental series 2. Results of a two-way ANOVA of series 2 for single treatment (As2O3 17x–18x, 21x–23x, 28x, 30x, and 33x) and control (unsuccussed and succussed water) groups, analysed over n = 5 experiments in early (day 0–3) and late time period (day 3–9). df—degree of freedom. Significant values are printed bold.
| Series 2 | df | Sum of Squares | F Ratio | |
|---|---|---|---|---|
| Treatment group | 9 | 0.00063312 | 0.6484 | 0.7553 |
| Experiment number | 4 | 0.16981641 | 391.2808 |
|
| Interaction | 36 | 0.00454901 | 1.1646 | 0.245 |
|
|
|
|
|
|
| Treatment group | 9 | 0.00073737 | 1.1146 | 0.3517 |
| Experiment number | 4 | 0.02844692 | 96.7118 |
|
| Interaction | 36 | 0.00223863 | 0.8456 | 0.723 |
Figure 8Mean relative growth rate (± 95% CI) of duckweed treated with either potentised As2O3 (potency levels 17x–18x, 21x–23x, 28x, 30x, 33x, n = 25 each) or water as control (unsuccussed and succussed water samples, n = 85 each) in n = 5 independent experiments of series 2. (A) Early time period (day 0–3), (B) Late time period (day 3–9). The red line represents the mean of water controls.
Statistical analysis of experimental series 1 and 2. Results of three-way ANOVA for numerically pooled treatment (As2O3 17x–18x, 21x–23x, 28x, 30x, and 33x) and numerically pooled control groups (unsuccussed and succussed water) for n = 2 experimental series with n = 5 independent experiments, for the early (day 0–3) and late time period (day 3–9). df—degree of freedom. * = interaction between independent ANOVA factors. Significant values are printed bold.
| Pool Series 1 + 2 | df | Sum of Squares | F Ratio | |
|---|---|---|---|---|
| Treatment group (tg) | 1 | 0.00000529 | 0.0372 | 0.8471 |
| Experiment number (en) | 4 | 0.14827807 | 260.594 |
|
| Experimental series (es) | 1 | 0.01723593 | 121.1664 |
|
| tg * en | 4 | 0.00063099 | 1.1089 | 0.3511 |
| tg * es | 1 | 0.00000264 | 0.0186 | 0.8916 |
| en * es | 4 | 0.13905187 | 244.3792 |
|
| tg * en * es | 4 | 0.00015998 | 0.2812 | 0.8902 |
|
|
|
|
|
|
| Treatment group (tg) | 1 | 0.00048419 | 6.787 |
|
| Experiment number (en) | 4 | 0.05417827 | 189.8587 |
|
| Experimental series (es) | 1 | 0.01532783 | 214.8553 |
|
| tg * en | 4 | 0.00053627 | 1.8793 | 0.1122 |
| tg * es | 1 | 0.00000503 | 0.0706 | 0.7906 |
| en * es | 4 | 0.0399193 | 139.8905 |
|
| tg * en * es | 4 | 0.00015089 | 0.5288 | 0.7146 |
Figure 9Mean relative growth rate (±95% CI) of duckweed treated with either potentised As2O3 (potency levels 17x–18x, 21x–23x, 28x, 30x, 33x, numerically pooled, n = 400) or water as control (unsuccussed and succussed water samples, numerically pooled, n = 340) in the 10 independent experiments of series 1 and series 2. (A) Early time period (day 0–3), (B) Late time period (day 3–9), * p < 0.05.
Statistical analysis of series 1 and 2. Results of a three-way ANOVA for single treatment (As2O3 17x–18x, 21x–23x, 28x, 30x, and 33x) and control (unsuccussed and succussed water) groups for n = 2 experimental series with n = 5 independent experiments, for the early (day 0–3) and late time period (day 3–9). df—degree of freedom. * = interaction between independent ANOVA factors. Significant values are printed bold.
| Pool Series 1 + 2 | df | Sum of Squares | F Ratio | |
|---|---|---|---|---|
| Treatment group (tg) | 9 | 0.00029496 | 0.2216 | 0.9914 |
| Experiment number (en) | 4 | 0.11806456 | 199.581 |
|
| Experimental series (es) | 1 | 0.01398425 | 94.5581 |
|
| tg * en | 36 | 0.00418589 | 0.7862 | 0.8117 |
| tg * es | 9 | 0.00091647 | 0.6885 | 0.7197 |
| en * es | 4 | 0.11179632 | 188.9849 |
|
| tg * en * es | 36 | 0.00316782 | 0.595 | 0.972 |
|
|
|
|
|
|
| Treatment group (tg) | 9 | 0.00078236 | 1.1809 | 0.3042 |
| Experiment number (en) | 4 | 0.04162298 | 141.3617 |
|
| Experimental series (es) | 1 | 0.01252126 | 170.1009 |
|
| tg * en | 36 | 0.00246072 | 0.9286 | 0.5908 |
| tg * es | 9 | 0.00024958 | 0.3767 | 0.9463 |
| en * es | 4 | 0.03053381 | 103.7002 |
|
| tg * en * es | 36 | 0.0019505 | 0.736 | 0.8718 |
Figure 10Mean relative growth rate (±95% CI) of duckweed treated with either potentised As2O3 (potency levels 17x–18x, 21x–23x, 28x, 30x, 33x, n = 50 each) or water as control (unsuccussed and succussed water samples, n = 170 each) in the 10 independent experiments of series 1 and 2. (A) Early time period (day 0–3), (B) Late time period (day 3–9). The red line represents the mean of water controls.